Lakewood-Amedex Biotherapeutics Inc. (LABT) Free cash flow
Lakewood-Amedex Biotherapeutics Inc. (LABT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$5.7MFY2024
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$5.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice